Pharmacokinetics of cannabidiol following single oral and oral transmucosal administration in dogs

INTRODUCTION: In the last few years, different formulations containing cannabidiol (CBD) were tested with regard to its efficacy on chronic pain, refractory epilepsy, anxiety, aggressive behavior and atopic dermatitis in dogs. CBD is generally administered orally, but its low bioavailability, probab...

Descripción completa

Detalles Bibliográficos
Autores principales: della Rocca, Giorgia, Paoletti, Fabiola, Conti, Maria Beatrice, Galarini, Roberta, Chiaradia, Elisabetta, Sforna, Monica, Dall'Aglio, Cecilia, Polisca, Angela, Di Salvo, Alessandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Veterinary Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9859632/
https://www.ncbi.nlm.nih.gov/pubmed/36686155
http://dx.doi.org/10.3389/fvets.2022.1104152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9859632/
https://www.ncbi.nlm.nih.gov/pubmed/36686155
http://dx.doi.org/10.3389/fvets.2022.1104152

Ejemplares similares